0001193125-24-000224.txt : 20240102 0001193125-24-000224.hdr.sgml : 20240102 20240102074636 ACCESSION NUMBER: 0001193125-24-000224 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240102 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XOMA Corp CENTRAL INDEX KEY: 0000791908 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522154066 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39801 FILM NUMBER: 24500246 BUSINESS ADDRESS: STREET 1: 2200 POWELL STREET STREET 2: SUITE 310 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-204-7239 MAIL ADDRESS: STREET 1: 2200 POWELL STREET STREET 2: SUITE 310 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: XOMA LTD /DE/ DATE OF NAME CHANGE: 19990107 FORMER COMPANY: FORMER CONFORMED NAME: XOMA CORP /DE/ DATE OF NAME CHANGE: 19920703 8-K 1 d602001d8k.htm 8-K 8-K
XOMA Corp DE false 0000791908 0000791908 2024-01-02 2024-01-02 0000791908 us-gaap:CommonStockMember 2024-01-02 2024-01-02 0000791908 us-gaap:SeriesAPreferredStockMember 2024-01-02 2024-01-02 0000791908 us-gaap:SeriesBPreferredStockMember 2024-01-02 2024-01-02

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): January 2, 2024

 

 

XOMA CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

 

 

DELAWARE   001-39801   52-2154066
(State or Other Jurisdiction
of Incorporation)		   (Commission
File Number)		   (I.R.S. Employer
Identification Number)

2200 Powell Street, Suite 310, Emeryville, California 94608

(Address of Principal Executive Offices) (Zip Code)

(510) 204-7200

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

  

Trading

symbol(s):

  

Name of each exchange
on which registered:

Common Stock, $0.0075 par value   XOMA   The Nasdaq Global Market
8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share   XOMAP   The Nasdaq Global Market
Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)   XOMAO   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 8.01

Other Events.

On January 2, 2024, XOMA Corporation issued a press release announcing a program to repurchase common stock, par value $0.0075 per share, with an aggregate value of up to $50 million through January 2027. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.		   

Description

99.1    Press release, dated January 2, 2024
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    XOMA CORPORATION
Date: January 2, 2024     By:  

/s/ THOMAS BURNS

      Thomas Burns
      Senior Vice President, Finance and Chief Financial Officer
 EX-99.1 2 d602001dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

XOMA Announces Stock Repurchase Program of up to $50 Million

Balanced capital allocation strategy looks to return capital to shareholders while continuing to invest in royalty and milestone acquisitions that will drive total shareholder return

EMERYVILLE, Calif., January 2, 2024 (GLOBE NEWSWIRE) – XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized XOMA’s first stock repurchase program, which permits the Company to purchase up to $50 million of XOMA’s common stock through January 2027.

“Upon arriving at XOMA, Brad Sitko, our Chief Investment Officer and I made it very clear that we intended to be active participants in our capital structure as we look to maximize shareholder value through prudent capital allocation,” stated Owen Hughes, Executive Chairman of XOMA. “Levering the future cashflow streams of our growing royalty portfolio by reducing our shares outstanding is one of several allocation strategies we plan to utilize to generate superior risk-adjusted, non-correlated returns for our investors.”

Under the program, management has discretion in determining the conditions under which shares may be purchased from time to time, including through transactions in the open market, in privately negotiated transactions, or by other means in accordance with applicable laws. The number, price, structure, and timing of the repurchases, if any, will be at XOMA’s sole discretion and repurchases will be evaluated by XOMA depending on market conditions, royalty and milestone acquisition opportunities, and other factors. The repurchase authorization does not oblige XOMA to acquire any particular amount of its common stock. The Board of Directors may suspend, modify, or terminate the stock repurchase program at any time without prior notice.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale is unlawful.

About XOMA Corporation

XOMA is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes. The Company has an extensive and growing portfolio with more than 70 assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate). For more information about the Company and its portfolio, please visit www.xoma.com.

Forward-Looking Statements/Explanatory Notes

Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the economic potential of XOMA’s royalty and milestone portfolio and intrinsic value of its business model and the timing and nature of common stock repurchases, if any, by XOMA. In some cases, you can identify such forward-looking statements by terminology such as “anticipate,” “intend,” “believe,” “estimate,” “plan,” “seek,” “project,” “expect,” “may,” “will”, “would,” “could” or “should,” the negative of these terms or similar expressions. These forward-looking statements are not a guarantee of any future events, and you should not place undue reliance on such statements. These statements are based on assumptions that may not prove accurate, and actual results could differ materially from those anticipated due to certain risks, including those described in more detail in XOMA’s most recent filing on Form 10-Q and in other filings with the Securities and Exchange Commission. Consider such risks carefully when considering XOMA’s prospects. Any forward-looking statement in this press release represents XOMA’s beliefs and assumptions only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. XOMA disclaims any obligation to update any forward-looking statement, except as required by applicable law.

EXPLANATORY NOTE: Any references to “portfolio” in this press release refer strictly to milestone and/or royalty rights associated with a basket of drug products in development. Any references to “assets” in this press release refer strictly to milestone and/or royalty rights associated with individual drug products in development.

As of the date of this press release, the assets in XOMA’s milestone and royalty portfolio, except VABYSMO® (faricimab) and IXINITY® [coagulation factor IX (recombinant)], are investigational compounds. Efficacy and safety have not been established. There is no guarantee that any of the investigational compounds will become commercially available.

# # #

 

Investor contact:

   

Media contact:

Juliane Snowden    Kathy Vincent
XOMA    KV Consulting & Management
+1-646-438-9754    +1-310-403-8951
juliane.snowden@xoma.com    kathy@kathyvincent.com
 EX-101.SCH 3 xoma-20240102.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 4 xoma-20240102_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 xoma-20240102_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock [Member] Common Stock [Member] Series A Preferred Stock [Member] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series B Preferred Stock [Member] EX-101.PRE 6 xoma-20240102_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g602001g1230003236023.jpg GRAPHIC begin 644 g602001g1230003236023.jpg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htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Jan. 02, 2024
Document And Entity Information [Line Items]  
Entity Registrant Name XOMA Corp
Entity Incorporation State Country Code DE
Amendment Flag false
Entity Central Index Key 0000791908
Document Type 8-K
Document Period End Date Jan. 02, 2024
Entity File Number 001-39801
Entity Tax Identification Number 52-2154066
Entity Address, Address Line One 2200 Powell Street
Entity Address, Address Line Two Suite 310
Entity Address, City or Town Emeryville
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94608
City Area Code (510)
Local Phone Number 204-7200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Common Stock, $0.0075 par value
Trading Symbol XOMA
Security Exchange Name NASDAQ
Series A Preferred Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share
Trading Symbol XOMAP
Security Exchange Name NASDAQ
Series B Preferred Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)
Trading Symbol XOMAO
Security Exchange Name NASDAQ
XML 9 d602001d8k_htm.xml IDEA: XBRL DOCUMENT 0000791908 2024-01-02 2024-01-02 0000791908 us-gaap:CommonStockMember 2024-01-02 2024-01-02 0000791908 us-gaap:SeriesAPreferredStockMember 2024-01-02 2024-01-02 0000791908 us-gaap:SeriesBPreferredStockMember 2024-01-02 2024-01-02 XOMA Corp DE false 0000791908 8-K 2024-01-02 001-39801 52-2154066 2200 Powell Street Suite 310 Emeryville CA 94608 (510) 204-7200 false false false false Common Stock, $0.0075 par value XOMA NASDAQ 8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share XOMAP NASDAQ Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share) XOMAO NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( -(](E@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #2/2)8.1M=$>X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$Y*#R;-I:.G#@8K;.QF;+4UBV-C:R1]^R5>FS*V!]C1TN]/ MGT"-#E+[B,_1!XQD,3V,KNN3U&'#SD1! B1]1J=2.27ZJ7GTT2F:GO$$0>D/ M=4*H.%^#0U)&D8(96(2%R-K&:*DC*O+QBC=ZP8?/V&68T8 =.NPI@2@%L':> M&"YCU\ =,,,(HTO?!30+,5?_Q.8.L&MR3'9)#<-0#G7.33L(>'O:O^1U"]LG M4KW&Z5>RDBX!-^PV^;7>/AYVK*UXM2JX*'AU$)5>-/=I_ M;'P3;!OX=1?M%U!+ P04 " #2/2)8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M -(](EC!"GW4:04 +T9 8 >&PO=V]R:W-H965T&UL MM9G_<]HV&,;_%1W[R9RNI+K32\X->2I79ZVP]?C&![%8&OM&>W1:L 6?_RH_KJZ>;B96Z;Y1*8?16*69ZU!BR1\SLK4?)"K7_CVAKI6+Y:I MKOZ3U>;:3K=%XE(;F6T; T$F\LTK>]AVQ$Z#0;"G =TVH!7WYHLJR@MFV.A4 MR151]FI0LP?5K5:M 4[D=E1F1L&G MJ9T86,2^AD0UB>D%>Y$69-+O/-:$.O MG;8-?(F]M!UO!<\W@G2/X*\L/R$!/2(TH)W/F[>!K0:D-2"M]"(?X+@1D'QZ M!PW(I>&9_KN)=J/>:5:W<_ZE+EC,SUHPJ357][PU^O&[L!?\C+!'-7N$J8^V MN!_X0FBC&-S$>Y;Q)DI@YY4FTZ<&68X?$.9 M&[6&UZ01$A>^>(70=6NZ+BHRAJ%.JN%^G;)%$P3>?LY2S1&.7LW1.Z27)D"B M6 J]E? '\I:OFXAPI0#^^L-P& P0K'Z-UE]DM5TU4N$80A,?1 M$W,1;XIN/Y]'LDN/:=CM!+T>1KB3 .$AA.,D M 0?41X\'I#+6Z[QQ7#V2%!8%9"I7$+;@+0K""2-U41"B;HV3WJQD(RDN.2L% M.%\4!AB@\_OP(,.O 2?V3"IR(U?-4>J1R[A:WXLTQ2PM=,X?'F3]-=W&]0%O MJN2]R./FD<8U)V,,S=E^B/OVEVA3J0WX[E^BV)M&'L5AIX=:;NBB(,0=O!K$ M,2QY]Z/@ B^Z8? 3AN+L/\0-_)V,H5>F2YEC]N81H4'GN \%BA&Y+ AQ"_^H MA#$\AZ[)LC+?6IMNI,*%?,D=N@@(R53$PHA\0:Y@@BO!TD8>7,7'0UT" M4-RNIXI7W<.APC;A#6L=_^$^O]3\5TP4-S&9SPNE64.Z2VY$>;+*-Q"XB*[8W5$O@]. M8$G>)053Y)ZE)3H?7$I0W.1O%$OL%)VMLUO9:#@> ;O)PTA<2%#_40 M+UF^X'MWG1ZA]^/9Q?@WC,G%!,7=?08VS#49PU*#@ZDHGAQ2.:CF4Z>>RQ$Z M?-[*00/FJ8\>7.Q$>$P<5CD>D<%)CW9_(/7P3+SX*\TC8"MMBJ&X?(H\NX>#2\TCY"VU:.>9 M$QY,V[$Z_U^EAFL^=:ZZD(J>-Z2BYPBIR(54]"U"RB-RP0NIA6%J36:V5C1Y MP5F\)(I7S'FUH W;81 $L 02.:QLN39P0-BFN(BOZU]8KM6B(7 MC='71J-'P!;L-8;BLC'Z5MGH$=I?L.V=A_'VAXTK9M>NFJ1\#DK!21^F@=K\ M5K Y,;*HGL_?2F-D5ATN.8,%N+T /I]+:1Y/["/_^A>;T;]02P,$% @ MTCTB6)^@&_"Q @ X@P T !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@ M;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W M)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP M4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W M8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM M5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLY MS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5B M'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0)P M:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X M3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3 MB.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0ERHY_U=3 M_ 102P,$% @ TCTB6)>*NQS $P( L !?3T\$MP> M:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5; M&GC3Y?YVX$G1H2)8%II%R=.B':5_'FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+ M2X3[+O,&@EXN1:T/9=1,92L88!.R '<(Y_A^[<#K3P&]'@!6^AC(,=D",Y1]XVXG\-/O4 M(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)'0.M#,,SQ;;!<.AHQ$5V9:// M8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND53 >"CVN*!.L>@PL(:EU&*AD MMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU M[D&P]_ :C1W-CQ^W_ %02P,$% @ TCTB6"0>FZ*M ^ $ !H !X M;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D M6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP M#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZT MYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( -(](EAED'F2&0$ ,\# 3 M 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP M 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=. M8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9 MP&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I& M0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC", MS[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^DX K @ $0 M@ &O 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " #2/2)8F5R<(Q & M "<)P $P @ ', 0 >&PO=&AE;64O=&AE;64Q+GAM;%!+ M 0(4 Q0 ( -(](EC!"GW4:04 +T9 8 " @0T( !X M;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;'-02P$"% ,4 " #2/2)899!YDAD! #/ P $P @ '" L$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" ,%0 ! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 4 23 1 false 3 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d602001d8k.htm xoma-20240102.xsd xoma-20240102_def.xml xoma-20240102_lab.xml xoma-20240102_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d602001d8k.htm": { "nsprefix": "xoma", "nsuri": "http://www.xoma.com/20240102", "dts": { "inline": { "local": [ "d602001d8k.htm" ] }, "schema": { "local": [ "xoma-20240102.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "definitionLink": { "local": [ "xoma-20240102_def.xml" ] }, "labelLink": { "local": [ "xoma-20240102_lab.xml" ] }, "presentationLink": { "local": [ "xoma-20240102_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 3, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 4, "entityCount": 1, "segmentCount": 3, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-01-02_to_2024-01-02", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d602001d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-01-02_to_2024-01-02", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d602001d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "xoma_DocumentAndEntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xoma.com/20240102", "localname": "DocumentAndEntityInformationLineItems", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "xoma_DocumentAndEntityInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xoma.com/20240102", "localname": "DocumentAndEntityInformationTable", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.xoma.com//20240102/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001193125-24-000224-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-000224-xbrl.zip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end